Search

everythinglearnresearchcommunity

for

Search:↓

Female pattern hair loss in Thailand varies by region and demographics, affecting diagnosis and treatment.

New biological pathways and potential treatment targets for male pattern baldness were identified.

A young patient with unusual insulin resistance and high testosterone levels had a rare INSR gene mutation.

Many COVID-19 patients experience temporary hair loss after infection, not linked to infection severity or treatment.

Excessive hair growth affects the quality of life of Iranian women with PCOS the most.

Mutations in certain receptors can cause diseases and offer new treatment options.

Finasteride treatment lowers urine androgen and prostaglandin levels, making them potential markers for effectiveness.

Women with PCOS should be screened for heart disease risk and manage their health to prevent it.

The guidelines advise against using testosterone and DHEA in women for most conditions due to safety and effectiveness concerns, but suggest considering testosterone for postmenopausal women with low sexual desire.

The document concludes that treating androgen excess needs patience, managing expectations is important, and many drugs used are not officially approved, suggesting cosmetic options for mild cases.

PCOS may be influenced by factors in the blood, not just the ovaries.

Antiandrogens and androgen inhibitors like spironolactone, finasteride, and dutasteride can treat hair loss and skin conditions, but they have risks and side effects, including potential harm to pregnant women and risks of cancer and heart issues. Herbal remedies also have antiandrogenic effects but lack safety validation.

AKR1C3 could be a treatment target for metabolic issues in PCOS.

Most women with excess male hormones have Polycystic Ovary Syndrome, and hormonal therapy can improve symptoms but may cause side effects.

Hirsutism is a strong sign of high male hormones and metabolic problems in women with PCOS, but acne and hair loss are not.

Women with androgen excess, especially those with PCOS, have a much higher risk of heart disease and stroke.

Hair loss in women not always linked to increased oil production; other factors may be involved.

Testing for CAG repeat polymorphism in the androgen receptor gene is not currently recommended for managing hypogonadism.

Men with hair loss have more DNA changes in back-of-head hair follicles, possibly protecting them from thinning.

A woman with a rare adrenal tumor and hormonal disorder had improved testosterone levels after surgery, but her menstrual irregularities continued.

Clascoterone is a new, effective, and safe acne treatment without systemic side effects.

Androgen measurements are mostly unnecessary for diagnosing PCOS, except in women with menstrual issues.

Doctors used a special blood sampling technique to diagnose a woman's rare ovarian tumor that was producing male hormones.

Researchers found a white halo around hair in most patients with a specific type of hair loss, which helps in early diagnosis and treatment.

Early onset hair loss linked to genetics and androgen levels.

Transgender patients face more barriers to oral healthcare, leading to poorer oral health and quality of life.

Polycystic ovary syndrome costs the U.S. over $4 billion a year, mainly from treating related health issues.

Men's hair loss is caused by hormones and genes, and can be treated with medication and surgery, while graying is due to aging and has no prevention except dyeing.

Androgens like testosterone are important hormones for both men and women, made differently in each sex and affecting the body by regulating genes and quick interactions with cell components.

Excess androgens may cause PCOS, not just be a symptom.